ライフサイエンスコーパス: chronic fatigue syndrome

1 ia syndrome), and malaise/fatigue (including chronic fatigue syndrome).

2 rosis, postpoliomyelitis, poststroke, and in chronic fatigue syndrome.

3 onal diagnostic criteria for neurasthenia or chronic fatigue syndrome.

4 marizes the current state of knowledge about chronic fatigue syndrome.

5 ilure, does not seem to be beneficial in the chronic fatigue syndrome.

6 versus relaxation therapy for patients with chronic fatigue syndrome.

7 re important in both chronic fatigue and the chronic fatigue syndrome.

8 There is mild hypocortisolism in chronic fatigue syndrome.

9 e one factor contributing to the symptoms of chronic fatigue syndrome.

10 a group of well-characterized patients with chronic fatigue syndrome.

11 ndromes such as irritable bowel syndrome and chronic fatigue syndrome.

12 tion syndrome, heat intolerance, and perhaps chronic fatigue syndrome.

13 xtent, physical disability for patients with chronic fatigue syndrome.

14 has been documented in both fibromyalgia and chronic fatigue syndrome.

15 een also documented in both fibromyalgia and chronic fatigue syndrome.

16 en parvovirus and Still's disease as well as chronic fatigue syndrome.

17 -traumatic stress disorder, and possibly the chronic fatigue syndrome.

18 e autoantibodies in sera of 60 patients with chronic fatigue syndrome.

19 tory evidence for an autoimmune component in chronic fatigue syndrome.

20 g the debilitating symptoms of patients with chronic fatigue syndrome.

21 sess suicidality adequately in patients with chronic fatigue syndrome.

22 case note entry) and received a diagnosis of chronic fatigue syndrome.

23 plus CBT and SMC plus GET for patients with chronic fatigue syndrome.

24 ing therapy (APT) plus SMC and SMC alone for chronic fatigue syndrome.

25 rt in perpetuating fatigue and disability in chronic fatigue syndrome.

26 in alleviating symptoms of depression and in chronic fatigue syndrome.

27 ced Motivation approached levels observed in chronic fatigue syndrome.

28 irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome.

29 be associated with human prostate cancer and chronic fatigue syndrome.

30 cialist medical care (SMC) for patients with chronic fatigue syndrome.

31 n association with human prostate cancer and chronic fatigue syndrome.

32 aretrovirus linked to prostate carcinoma and chronic fatigue syndrome.

33 n between the human gammaretrovirus XMRV and chronic fatigue syndrome.

34 actor for postinfectious irritable bowel and chronic fatigue syndromes.

35 d psychological distress in chronic pain and chronic fatigue syndromes.

36 d costs attributable to the chronic pain and chronic fatigue syndromes.

37 ts with prostate cancer and in patients with chronic fatigue syndromes.

38 igue and physical functioning in people with chronic fatigue syndrome 1 year after randomisation.

39 c neuropathy, 463; myalgic encephalomyelitis/chronic fatigue syndrome, 95; preload failure, 120; post

40 The chronic fatigue syndrome also presents problems in defin

41 n association with human prostate cancer and chronic fatigue syndrome, although these associations ar

42 ticipants meeting international criteria for chronic fatigue syndrome and 329 participants meeting Lo

43 ns from 121 consecutive clinic patients with chronic fatigue syndrome and 64 comparison subjects with

44 diagnostic biomarker of MMF in patients with chronic fatigue syndrome and cognitive dysfunction.

45 ing has confirmed an association between the chronic fatigue syndrome and orthostatic intolerance; ho

46 ntestinal microbiome have been identified in chronic fatigue syndrome and other neuropsychiatric diso

47 p with symptoms of myalgic encephalomyelitis/chronic fatigue syndrome and other post-acute infectious

48 illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachyc

49 syndromes such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachyc

50 sorders, coronary heart disease, cancer, and chronic fatigue syndrome and those remaining on their in

51 We sought predictors of both acute and chronic fatigue syndromes and mood disorders from clinic

52 , 'Dopamine and fibromyalgia', 'Dopamine and chronic fatigue syndrome' and 'Dopamine and irritable bo

53 l and nuclear envelope proteins was found in chronic fatigue syndrome, and an increased prevalence of

54 ntidepressants for irritable bowel syndrome, chronic fatigue syndrome, and chronic back pain were sel

55 ly associated with type I diabetes, obesity, chronic fatigue syndrome, and various manifestations of

56 l presentation, evaluation, and prognosis of chronic fatigue syndrome are discussed.

57 ed to SMC to moderately improve outcomes for chronic fatigue syndrome, but APT is not an effective ad

58 erapy is an effective and safe treatment for chronic fatigue syndrome, but it is therapist intensive

59 increased all-cause mortality in people with chronic fatigue syndrome, but our findings show a substa

60 herapy (GET) can be effective treatments for chronic fatigue syndrome, but patients' organisations ha

61 mors and in blood samples from patients with chronic fatigue syndrome, but these findings have not be

62 Cognitive behavior therapy for chronic fatigue syndrome can produce some lasting benefi

63 oymentloss in a case series of patients with Chronic Fatigue Syndrome (CFS) after the infection.

64 and overlapping with those characterised as chronic fatigue syndrome (CFS) and have been described a

65 et al's 1994 criteria were used to diagnose chronic fatigue syndrome (CFS) and idiopathic chronic fa

66 Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are associated with subst

67 Patients with chronic fatigue syndrome (CFS) are more likely than heal

68 present in the blood of 67% of patients with chronic fatigue syndrome (CFS) compared with 3.7% of hea

69 Recent reports showed many patients with chronic fatigue syndrome (CFS) harbor a retrovirus, xeno

70 Chronic Fatigue Syndrome (CFS) has been defined as unexp

71 Gulf War Illness (GWI) and Chronic Fatigue Syndrome (CFS) have similar profiles of

72 ophysiology, and treatment of postinfectious chronic fatigue syndrome (CFS) in adolescents.

73 orrectly associated with prostate cancer and chronic fatigue syndrome (CFS) in recent years.

74 tress disorder (PTSD) and illness resembling chronic fatigue syndrome (CFS) in the entire population

75 Chronic fatigue syndrome (CFS) is a complex, heterogeneo

76 yalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS) is a debilitating conditi

77 Chronic fatigue syndrome (CFS) is a debilitating disease

78 Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a debilitating multisy

79 Chronic fatigue syndrome (CFS) is a disabling condition

80 Chronic fatigue syndrome (CFS) is a multisystem disorder

81 Chronic fatigue syndrome (CFS) is a serious systemic ill

82 Chronic fatigue syndrome (CFS) is an important public he

83 Chronic fatigue syndrome (CFS) is associated with a dysr

84 diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical crit

85 Chronic fatigue syndrome (CFS) is characterized by sever

86 The pathogenesis of Chronic Fatigue Syndrome (CFS) is yet unknown.

87 man and Das Gupta, analyzed DNA samples from chronic fatigue syndrome (CFS) patients and healthy cont

88 ported differences in the immune function of chronic fatigue syndrome (CFS) patients are detectable i

89 Chronic fatigue syndrome (CFS) patients often suffer fro

90 Chronic fatigue syndrome (CFS) remains poorly understood

91 with acute sinusitis (n = 25), subjects with chronic fatigue syndrome (CFS) with nonallergic rhinitis

92 nostic criterion for Gulf War Illness (GWI), Chronic Fatigue Syndrome (CFS), and fibromyalgia (FM).

93 e dysfunction may be common in patients with chronic fatigue syndrome (CFS).

94 been used in the treatment and management of chronic fatigue syndrome (CFS).

95 ory cytokine, is suspected to play a role in chronic fatigue syndrome (CFS).

96 laint of fatigue, a small number suffer from chronic fatigue syndrome (CFS).

97 h published criteria used to define cases of chronic fatigue syndrome (CFS).

98 n measures of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS).

99 s similar to those reported by patients with chronic fatigue syndrome (CFS).

100 e living with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS).

101 er found in a high percentage of humans with chronic fatigue syndrome (CFS).

102 d mononuclear cells (PBMCs) of patients with chronic fatigue syndrome (CFS).

103 to be present in the blood of patients with chronic fatigue syndrome (CFS).

104 (XMRV), have been controversially linked to chronic fatigue syndrome (CFS).

105 rauma appears to be a potent risk factor for chronic fatigue syndrome (CFS).

106 Certain infections can trigger chronic fatigue syndromes (CFS) in a minority of people

107 ticipants were recruited from six specialist chronic fatigue syndrome clinics in the UK National Heal

108 nces in understanding the pathophysiology of chronic fatigue syndrome continue to demonstrate the inv

109 dds ratio, 2.32 [95% CI, 1.02 to 5.27]); the chronic fatigue syndrome (deployed, 1.6%; nondeployed 0.

110 outcome measures included fibromyalgia, the chronic fatigue syndrome, dermatologic conditions, dyspe

111 Patients with chronic fatigue syndrome experience significant function

112 Conditions examined were the chronic fatigue syndrome, fibromyalgia, the irritable bo

113 We identified 2147 cases of chronic fatigue syndrome from CRIS and 17 deaths from Ja

114 for Health and Care Excellence criteria for chronic fatigue syndrome from two secondary-care clinics

115 Although chronic fatigue syndrome has significant symptom overlap

116 yndrome, Turner syndrome, Williams syndrome, chronic fatigue syndrome, IgA nephropathy, and IgA defic

117 tober 2012 as part of the Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology

118 ated mortality in individuals diagnosed with chronic fatigue syndrome in secondary and tertiary care

119 kinsonism', 'Functional somatic syndromes', 'Chronic fatigue syndrome', 'Irritable bowel syndrome', '

120 Chronic fatigue syndrome is a controversial condition es

121 s exist across many domains, suggesting that chronic fatigue syndrome is a heterogeneous condition of

122 Chronic fatigue syndrome is an illness characterized by

123 Myalgic encephalomyelitis/chronic fatigue syndrome is an unexplained debilitating

124 Chronic fatigue syndrome is diagnosed on the basis of sy

125 The prevalence of chronic fatigue syndrome is much less than that of fibro

126 arch on the pathophysiology and treatment of chronic fatigue syndrome is reviewed.

127 Treatment for chronic fatigue syndrome is symptom-based and includes p

128 Mortality associated with chronic fatigue syndrome is uncertain.

129 Chronic fatigue syndrome is unlikely to be caused or mai

130 Reports of mild hypocortisolism in chronic fatigue syndrome led us to postulate that low-do

131 tions, perception of health as fair or poor, chronic fatigue syndrome-like illness, and posttraumatic

132 Myalgic encephalomyelitis/chronic fatigue syndrome-like symptoms, upper respirator

133 ies to myalgic encephalomyelitis also called chronic fatigue syndrome linked to a viral and autoimmun

134 sses (CMI) such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Long-COVID, and Gulf War Illne

135 In some patients with chronic fatigue syndrome, low-dose hydrocortisone reduce

136 Evidence also is beginning to emerge that chronic fatigue syndrome may be familial.

137 ical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM), we relied on expert cli

138 Myalgic encephalomyelitis/chronic fatigue syndrome (ME) is a severe, debilitating

139 Research of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM),

140 Long COVID (LC), Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and healthy control su

141 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are per

142 People living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) experience heterogeneo

143 illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have long been linked

144 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) involves severe fatigu

145 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) involves severe fatigu

146 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and debil

147 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic debilitat

148 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic illness w

149 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic d

150 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease c

151 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease w

152 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex heterogen

153 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multisyst

154 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, debilita

155 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating mult

156 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a highly debilitati

157 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a medically unexpla

158 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by va

159 Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is commonly associated

160 The etiology of myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is unknown, but involv

161 Myalgic Encephalomyelitis or chronic fatigue syndrome (ME/CFS) lacks objective diagno

162 onset (GO-ME/CFS) myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) manifest similar sympt

163 dely implicated in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) pathogenesis.

164 and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a disabling long-term

165 ical features with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), suggest the potential

166 n patients with myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), the data are limited

167 overlap with PASC, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), though studies have y

168 ocyte depletion in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

169 ple suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

170 the definition of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

171 9," reminiscent of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

172 ymptoms resembling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

173 tious diseases and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

174 United States have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

175 l test to diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

176 (BD), schizophrenia (SZ), anxiety disorder, chronic fatigue syndrome, multiple sclerosis, amyotrophi

177 group, is marketed as a diagnostic test for chronic fatigue syndrome/Myalgic Encephalomyelitis (CFS/

178 Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/

179 Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/

180 ted from the following 5 groups of patients: chronic fatigue syndrome (n = 32), human immunodeficienc

181 pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsy

182 o association between XMRV and patients with chronic fatigue syndrome or chronic immunomodulatory con

183 Chronic fatigue syndrome or myalgic encephalomyelitis (C

184 ercise-associated syncope, eating disorders, chronic fatigue syndrome, or history of congenital heart

185 prostate cancer patients and in the blood of chronic fatigue syndrome patients.

186 Post-infectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a disabling diso

187 physician-diagnosed multisymptom conditions: chronic fatigue syndrome, posttraumatic stress disorder,

188 rostate cancer and myalgic encephalomyelitis/chronic fatigue syndrome, recent data indicate that resu

189 was significantly lower in the subjects with chronic fatigue syndrome regardless of the presence or a

190 is the way in which chronic fatigue and the chronic fatigue syndrome relate to each other: Is one th

191 -related virus (XMRV) in prostate cancer and chronic fatigue syndrome reported in previous studies re

192 and the Trans-NIH Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research Working Group.

193 The assessment and treatment of chronic fatigue syndrome should be multidimensional and

194 with an increased risk for fibromyalgia, the chronic fatigue syndrome, skin conditions, dyspepsia, an

195 se alterations are a cause or consequence of chronic fatigue syndrome still remains unanswered.

196 d worse health, or had a history of obesity, chronic fatigue syndrome, substance abuse, an eating dis

197 CD4(+) T cells and B cells of patients with chronic fatigue syndrome, suggesting an association betw

198 the Gulf War syndrome, chronic whiplash, the chronic fatigue syndrome, the irritable bowel syndrome,

199 c fatigue, and this is probably true for the chronic fatigue syndrome, too.

200 virus, XMRV, in blood cells of patients with chronic fatigue syndrome," two of the coauthors, Silverm

201 ng the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome was cosponsored by the NIH Offi

202 havior therapy versus relaxation therapy for chronic fatigue syndrome were invited to complete self-r

203 trial, patients meeting Oxford criteria for chronic fatigue syndrome were recruited from six seconda

204 mptom Screener for myalgic encephalomyelitis/chronic fatigue syndrome) were assessed at baseline and

205 y (1.39, 0.60-2.73; p=0.45) in patients with chronic fatigue syndrome when compared with the general

206 rial of patients meeting Oxford criteria for chronic fatigue syndrome who were recruited from six sec

207 e can anticipate that discrete causes of the chronic fatigue syndrome will be found in the future, ev

208 32 patients met our strict criteria for chronic fatigue syndrome without co-morbid psychiatric d